cardiovascular (CV) disease
Showing 1 - 25 of >10,000
Patient-Perceived Versus Trial in Shatin (Cardiovascular prevention guidelines)
Not yet recruiting
- Patient-Perceived Versus
- Cardiovascular prevention guidelines
-
Shatin, Hong KongThe Chinese University of Hong Kong
Jan 12, 2023
Sars-CoV2, Covid19, Cardiovascular Diseases Trial in Barcelona
Active, not recruiting
- Sars-CoV2
- +3 more
-
Barcelona, Catalonia, SpainHospital Clínic of Barcelona
Aug 22, 2022
Type 2 Diabetes Trial (Ertugliflozin, Placebo, Glycemic Rescue)
Atherosclerotic Cardiovascular Disease, End Stage Kidney Disease Trial (CSL300, Placebo)
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- End Stage Kidney Disease
- CSL300
- Placebo
- (no location specified)
Aug 1, 2022
Rheumatoid Arthritis, Cardiovascular Disease Trial in Boston (certolizumab, Stress myocardial perfusion PET)
Active, not recruiting
- Rheumatoid Arthritis
- Cardiovascular Disease
- certolizumab
- Stress myocardial perfusion PET
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 18, 2022
Atherosclerotic Cardiovascular Disease, STEMI, Non STEMI Trial in Netherlands
Enrolling by invitation
- Atherosclerotic Cardiovascular Disease
- +2 more
-
Alkmaar, Netherlands
- +12 more
Dec 12, 2022
CV Imaging of Metabolic Interventions
Recruiting
- Bariatric Surgery Candidate
- +2 more
- MRI
-
Cleveland, OhioCardiovascular Innovation Research Center
Dec 5, 2022
Stress Disorders, Post-Traumatic Trial in Decatur (procedure, behavioral, drug)
Suspended
- Stress Disorders, Post-Traumatic
- Microneurography
- +7 more
-
Decatur, GeorgiaAtlanta VA Medical Center
Jan 20, 2022
Cardiovascular Risk, Cardiovascular Prevention Trial in United States (CV Prevention Choice Tool, Implementation Facilitation
Enrolling by invitation
- Cardiovascular Risk
- Cardiovascular Prevention
- CV Prevention Choice Tool
- Implementation Facilitation Strategies
-
Marietta, Georgia
- +3 more
Sep 3, 2022
Inclisiran on Major Adverse Cardiovascular Events in French
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- Inclisiran sodium
- +3 more
- (no location specified)
Jul 26, 2023
Atherosclerosis, Cardiovascular Diseases Trial in Cambridge (Alirocumab 150 MG/ML, Ezetimibe 10Mg Tablet, Atorvastatin 40Mg
Active, not recruiting
- Atherosclerosis
- Cardiovascular Diseases
- Alirocumab 150 MG/ML
- +6 more
-
Cambridge, Cambridgeshire, United KingdomAddenbrooke's Hospital
Jul 22, 2021
Heart Diseases, Diabetes, Type 2, Pre-diabetes Trial in Minneapolis (Cardiovascular Risk Homeless Support)
Active, not recruiting
- Heart Diseases
- +4 more
- Cardiovascular Risk Homeless Support
-
Minneapolis, MinnesotaHennepin Healthcare Research Institute
Aug 29, 2023
Selected Factors on Cardiovascular System in Chronic Kidney
Completed
- Atherosclerosis of Artery
- +4 more
- laboratory parameters - complete blood count
- +23 more
-
Poznań, PolandPoznan University of Medical Sciences
Jan 25, 2022
Diabetes, Type 2, PreDiabetes, Metabolic Syndrome Trial (The Cleerly CAD Staging System)
Not yet recruiting
- Diabetes Mellitus, Type 2
- +2 more
- The Cleerly CAD Staging System
- (no location specified)
Oct 31, 2023
Oral Health in Adults: Social Gradients and Correlation With
Enrolling by invitation
- Oral Disease
- +2 more
-
Bergen, NorwayOral Health Centre of Expertice
Feb 24, 2023
Cardiovascular Prevention, Screening, Peripheral Artery Disease Trial (HELENA)
Not yet recruiting
- Cardiovascular Prevention
- +4 more
- HELENA
- (no location specified)
May 23, 2023
Primary Prevention of Atherosclerotic Cardiovascular Disease Trial (Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran)
Not yet recruiting
- Primary Prevention of Atherosclerotic Cardiovascular Disease
- Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
- Placebo in 1.5ml
- (no location specified)
Feb 13, 2023
Cardiovascular Diseases Trial in Roma (sample blood)
Active, not recruiting
- Cardiovascular Diseases
- sample blood
-
Roma, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 24, 2023
Cardiovascular Diseases Trial in Atlanta (#HerHeart tool)
Recruiting
- Cardiovascular Diseases
- #HerHeart tool
-
Atlanta, Georgia
- +1 more
Nov 10, 2022
Tonometry(1) and Duplex Ultrasound(2) to Predict CV Events in to
Recruiting
- Abdominal Aortic Aneurysm
- Cardiovascular Events
- Carotid Artery Reactivity test (CAR test)
- Arterial Stiffness
-
Nijmegen, Gelderland, Netherlands
- +6 more
Nov 10, 2022
Psoriasis, Psoriatic Arthritis, Psoriatic Conditions Trial (Care Coordinator Model)
Not yet recruiting
- Psoriasis
- +3 more
- Care Coordinator Model
- (no location specified)
Jun 7, 2023
Primary Cardiovascular Events Using the Multimarker Approach
Completed
- Cardiovascular Diseases
- +4 more
- measurement of multiple biomarkers
- (no location specified)
Jan 19, 2023
Early Detection of Cardiovascular Disease
Completed
- Atheroma
- +5 more
- Ultrasound
-
Kingston, Ontario, CanadaQueen's University, Cardiovascular Imaging Network at Queen's (C
Jun 8, 2022
Heart Attack, Stroke, Cardiovascular Diseases Trial in Portland (CV WIZARD)
Active, not recruiting
- Heart Attack
- +2 more
- CV WIZARD
-
Portland, OregonKaiser Permanente Center for Health Research
May 25, 2022